Phenotype | Number observed | Percentage |
---|
PG-AP-E | 2 | 2.7 |
PG-AP-Ox | 16 | 20.5 |
PG-AP-Ox-VA | 6 | 7.7 |
PG-AP-TMX-Ox | 1 | 1.3 |
PG-AP-AC-E-Ox-VA | 3 | 3.8 |
PG-AP-AC-E-CRO-Ox | 15 | 19.2 |
PG-AP-AC-E-CRO-Ox-VA | 2 | 2.7 |
PG-AP-AC-E-TMX-Ox-VA | 1 | 1.3 |
PG-AP-AC-E-TMX-Ox | 2 | 2.7 |
PG-AP-AC-TMX-Ox-VA | 1 | 1.3 |
- Note: The percentage representations of the phenotypes were obtained by dividing the number of a particular phenotype by the total number of multiple antibiotic resistant isolates identified in a given area. VA, Vancomycin; AP, Ampicillin; PG, Penicillin G; TMP-SMX, Trimethoprime-Sulfamethoxazole; E, Erythromycin; Ox, Oxacillin ; CRO, Ceftriaxone; CIP, Ciprofloxacin; AC, Amoxicillin-Clavulanic Acid.